Skip to main content
Erschienen in: Tumor Biology 2/2014

01.02.2014 | Research Article

Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells

verfasst von: Yin-Xiang Lu, Xi-Can Yu, Mei-Ying Zhu

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

We aimed to investigate the antitumor effect and mechanism of fructose 1,6-bisphosphate (F1,6BP) in a hepatocellular carcinoma cell line. HepG2 cells were treated with different concentrations of F1,6BP alone or in combination with antioxidant N-acetyl-l-cysteine (NAC) or catalase (CAT), and cell proliferation assays were performed. Nuclear morphology was observed by fluorescence microscopy after Hoechst staining, and apoptosis was measured with flow cytometry. Changes in reactive oxygen species (ROS) levels in HepG2 cells were detected by 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. A colorimetric assay was adopted to determine the percentage of oxidized glutathione in these cells. CAT and glutathione peroxidase (GSH-Px) mRNA expression levels in HepG2 cells were measured by real-time fluorescence quantitative PCR. HepG2 cell proliferation was significantly inhibited by F1,6BP, accompanied by an increase in intracellular ROS levels and oxidized glutathione. Upregulated apoptosis and characteristic nuclear morphological changes were observed, and the expression of CAT and GSH-Px mRNA was increased after F1,6BP treatment. The antitumor effect of F1,6BP was significantly decreased after pretreatment with NAC and CAT in HepG2 cells. In conclusion, F1,6BP can induce the apoptosis of HepG2 cells. The mechanism involved may be associated with the generation of ROS, especially the production of H2O2.
Literatur
1.
Zurück zum Zitat Han DJ, Kim JB, Park SY, et al. Growth inhibition of hepatocellular carcinoma Huh7 cells by Lactobacillus casei extract. Yonsei Med J. 2013;54:1186–93.PubMedCentralPubMedCrossRef Han DJ, Kim JB, Park SY, et al. Growth inhibition of hepatocellular carcinoma Huh7 cells by Lactobacillus casei extract. Yonsei Med J. 2013;54:1186–93.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Jihye C, Jinsil S, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54(5):1178–85.CrossRef Jihye C, Jinsil S, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54(5):1178–85.CrossRef
3.
Zurück zum Zitat Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol. 2008;23:467–73.PubMedCrossRef Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol. 2008;23:467–73.PubMedCrossRef
4.
Zurück zum Zitat Nel I, Baba HA, Ertle J, et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol. 2013;6(4):420–8.PubMedCentralPubMed Nel I, Baba HA, Ertle J, et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol. 2013;6(4):420–8.PubMedCentralPubMed
5.
Zurück zum Zitat De Raedt T, Walton Z, Yecies JL, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011;20(3):400–13.PubMedCentralPubMedCrossRef De Raedt T, Walton Z, Yecies JL, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011;20(3):400–13.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Mauro C, Leow SC, Anso E, et al. NF-κB controls energy homeostasis and metabolic adaptation by up-regulating mitochondrial respiration. Nat Cell Biol. 2011;13(10):1272–9.PubMedCentralPubMedCrossRef Mauro C, Leow SC, Anso E, et al. NF-κB controls energy homeostasis and metabolic adaptation by up-regulating mitochondrial respiration. Nat Cell Biol. 2011;13(10):1272–9.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Lian XY, Khan FA, Stringer JL. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci. 2007;27(44):12007–11.PubMedCrossRef Lian XY, Khan FA, Stringer JL. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci. 2007;27(44):12007–11.PubMedCrossRef
8.
Zurück zum Zitat Gourlay CW, Ayscough KR. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci. 2005;118(Pt 10):2119–32.PubMedCrossRef Gourlay CW, Ayscough KR. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci. 2005;118(Pt 10):2119–32.PubMedCrossRef
9.
Zurück zum Zitat Debnath T, Park SR, da Kim H, et al. Anti-oxidant and anti-inflammatory activities of inonotus obliquus and germinated brown rice extracts. Molecules. 2013;18(8):9293–304.PubMedCrossRef Debnath T, Park SR, da Kim H, et al. Anti-oxidant and anti-inflammatory activities of inonotus obliquus and germinated brown rice extracts. Molecules. 2013;18(8):9293–304.PubMedCrossRef
10.
Zurück zum Zitat Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10(3):175–6.PubMedCrossRef Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10(3):175–6.PubMedCrossRef
11.
Zurück zum Zitat Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10(3):241–52.PubMedCrossRef Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10(3):241–52.PubMedCrossRef
12.
Zurück zum Zitat Chen W, Zhao Z, Li L, et al. Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radio Biol Med. 2008;45(1):60–72.CrossRef Chen W, Zhao Z, Li L, et al. Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radio Biol Med. 2008;45(1):60–72.CrossRef
13.
Zurück zum Zitat Kim AD, Kang KA, Kim HS, et al. A ginseng metabolite, compound K, induces artophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis. 2013;4:e750.PubMedCentralPubMedCrossRef Kim AD, Kang KA, Kim HS, et al. A ginseng metabolite, compound K, induces artophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis. 2013;4:e750.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Rasul A, Di J, Millimouno FM, et al. Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 2013;18(8):9382–96.PubMedCrossRef Rasul A, Di J, Millimouno FM, et al. Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 2013;18(8):9382–96.PubMedCrossRef
15.
16.
Zurück zum Zitat Cuesta E, Boada J, Calafell R, et al. Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by d-galactosamine in rats. Crit Care Med. 2006;34(3):807–14.PubMed Cuesta E, Boada J, Calafell R, et al. Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by d-galactosamine in rats. Crit Care Med. 2006;34(3):807–14.PubMed
17.
Zurück zum Zitat Alva N, Cruz D, Sanchez S, et al. Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats. Nitric Oxide. 2013;28:17–23.PubMedCrossRef Alva N, Cruz D, Sanchez S, et al. Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats. Nitric Oxide. 2013;28:17–23.PubMedCrossRef
18.
Zurück zum Zitat Burlacu A, Jinga V, Gafencu AV, et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 2001;306(3):409–16.PubMedCrossRef Burlacu A, Jinga V, Gafencu AV, et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 2001;306(3):409–16.PubMedCrossRef
Metadaten
Titel
Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells
verfasst von
Yin-Xiang Lu
Xi-Can Yu
Mei-Ying Zhu
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1231-z

Weitere Artikel der Ausgabe 2/2014

Tumor Biology 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.